Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Hum Genome Var ; 10(1): 20, 2023 Jun 23.
Article in English | MEDLINE | ID: mdl-37353494

ABSTRACT

HCN1 is one of four genes encoding hyperpolarization-activated cyclic nucleotide-gated channels. The phenotypic spectrum associated with HCN1 variants ranges from neonatal developmental and epileptic encephalopathy to idiopathic generalized epilepsy. We report a Japanese patient with repetitive focal seizures and super-refractory status epilepticus since early infancy caused by a de novo HCN1 variant, NM_021072.4, c.1195T>C, p.(Ser399Pro). This variant might have a dominant-negative effect on channel function, leading to severe epileptic encephalopathy.

2.
Nat Commun ; 12(1): 2107, 2021 04 08.
Article in English | MEDLINE | ID: mdl-33833240

ABSTRACT

Vacuolar H+-ATPases (V-ATPases) transport protons across cellular membranes to acidify various organelles. ATP6V0A1 encodes the a1-subunit of the V0 domain of V-ATPases, which is strongly expressed in neurons. However, its role in brain development is unknown. Here we report four individuals with developmental and epileptic encephalopathy with ATP6V0A1 variants: two individuals with a de novo missense variant (R741Q) and the other two individuals with biallelic variants comprising one almost complete loss-of-function variant and one missense variant (A512P and N534D). Lysosomal acidification is significantly impaired in cell lines expressing three missense ATP6V0A1 mutants. Homozygous mutant mice harboring human R741Q (Atp6v0a1R741Q) and A512P (Atp6v0a1A512P) variants show embryonic lethality and early postnatal mortality, respectively, suggesting that R741Q affects V-ATPase function more severely. Lysosomal dysfunction resulting in cell death, accumulated autophagosomes and lysosomes, reduced mTORC1 signaling and synaptic connectivity, and lowered neurotransmitter contents of synaptic vesicles are observed in the brains of Atp6v0a1A512P/A512P mice. These findings demonstrate the essential roles of ATP6V0A1/Atp6v0a1 in neuronal development in terms of integrity and connectivity of neurons in both humans and mice.


Subject(s)
Brain Diseases/genetics , Brain/growth & development , Neurons/physiology , Neurotransmitter Agents/metabolism , Vacuolar Proton-Translocating ATPases/genetics , Animals , Autophagosomes/pathology , Brain Mapping/methods , Cathepsin D/metabolism , Cell Line , HEK293 Cells , Humans , Loss of Function Mutation/genetics , Lysosomes/pathology , Magnetic Resonance Imaging/methods , Mechanistic Target of Rapamycin Complex 1/metabolism , Mice , Mutation, Missense/genetics , Neurons/cytology , Synaptic Vesicles/pathology
3.
Neuropediatrics ; 50(6): 391-394, 2019 12.
Article in English | MEDLINE | ID: mdl-31486053

ABSTRACT

The complication of anarthria in hereditary spastic paraplegia (HSP) patients has been reported to result from mutations in either ALS2 or FA2H. Here, we present a case of a 12-year-old boy with hereditary spastic paralysis and anarthria associated with a SPAST mutation. Initial presentation was at 14 months of age, when the patient experienced leg stiffness. At 3 years of age, he could speak well using sentences. At 9 years of age, he was found to have dysarthria and had difficulty writing. At 12 years of age, the ability to speak was lost. The patient could not vocalize any words, despite contraction of his neck and respiratory muscles during attempted vocalization. Additionally, the patient has never walked independently in his life. Considering these symptoms, we diagnosed him as having infantile onset ascending hereditary spastic paralysis (IAHSP) complicated with anarthria. By whole-exome sequencing, we discovered a heterozygous SPAST mutation c.1496G > A (p.Arg499His), which was not found in the parents and is probably de novo. This mutation was already repeatedly described with similar phenotype. Our results suggest that the p.Arg499His mutation in SPAST should be considered as a differential diagnosis in IAHSP.


Subject(s)
Dysarthria/genetics , Spastic Paraplegia, Hereditary/genetics , Spastin/genetics , Age of Onset , Child , Dysarthria/etiology , Exome/genetics , Handwriting , Humans , Male , Mutation/genetics , Phenotype , Spastic Paraplegia, Hereditary/complications , Speech Disorders/etiology , Walking
4.
Brain Dev ; 39(3): 266-270, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27743887

ABSTRACT

Cerebral folate deficiency due to folate receptor 1 gene (FOLR1) mutations is an autosomal recessive disorder resulting from a brain-specific folate transport defect. It is characterized by late infantile onset, severe psychomotor regression, epilepsy, and leukodystrophy. We describe a consanguineous girl exhibiting severe developmental regression, intractable epilepsy, polyneuropathy, and profound hypomyelination with cortical involvement. Magnetic resonance imaging showed cortical disturbances in addition to profound hypomyelination and cerebellar atrophy. Nerve conduction studies revealed both axonal degeneration and demyelinating features. A diagnosis of cerebral folate deficiency was confirmed by a homozygous c.466T>G (p.W156G) mutation in FOLR1, coupled with extremely low cerebrospinal fluid levels of 5-methyltetrahydrofolate. Her symptoms, neuroradiological findings, and polyneuropathy were alleviated by oral folinic acid treatment in conjunction with intravenous and intramuscular administration therapy. Our patient shows that folinic acid therapy can ameliorate the clinical symptoms, white matter disturbances, cortical insults, and peripheral neuropathy of cerebral folate deficiency caused by FOLR1 mutation. It is important to recognize these clinical symptoms and make a precise diagnosis early on, because cerebral folate deficiency is treatable.


Subject(s)
Folate Receptor 1/metabolism , Folic Acid Deficiency/genetics , Leukoencephalopathies/genetics , Mutation/genetics , Peripheral Nervous System Diseases/genetics , Child , Epilepsy/complications , Epilepsy/genetics , Female , Folate Receptor 1/deficiency , Folic Acid Deficiency/diagnosis , Humans , Leukoencephalopathies/diagnosis , Leukoencephalopathies/pathology , Magnetic Resonance Imaging/methods , Peripheral Nervous System Diseases/diagnosis , Peripheral Nervous System Diseases/pathology
5.
Brain Dev ; 38(3): 285-92, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26482601

ABSTRACT

OBJECTIVE: Recent studies have elucidated causative roles for genetic abnormalities in early-onset epileptic encephalopathies (EOEE). Accompanying characteristic features, in addition to seizures, have also been suggested to provide important clues for an early and accurate genetic diagnosis of affected patients. In this study, we investigated the underlying genetic causes in patients with EOEE associated with infantile movement disorders. METHODS: We examined 11 patients with EOEE and involuntary movements (nine with West syndrome and two with nonsyndromic epileptic encephalopathy). All showed severe developmental delay, cognitive impairment, and involuntary movements such as chorea, ballism, dyskinesia or myoclonus, and hand stereotypies. We performed whole-exome sequencing of 10 patients, while the other patient underwent high-resolution melting analysis of candidate EOEE genes. RESULTS: We identified mutations in CDKL5, SCN2A, SETD5, ALG13, and TBL1XR1 in seven patients with West syndrome, and in SCN1A and GRIN1 in the two patients with unclassified epileptic encephalopathy. All mutations were validated as de novo events. The genetic cause was undetermined in the remaining two patients. CONCLUSIONS: We found pathogenic mutations in seven genes, in nine of 11 patients with EOEE and involuntary movements. Although the results of our study are preliminary because of the small number of patients, they nevertheless suggest that specific accompanying phenotypes such as hyperkinetic movements or hand stereotypies could be important in narrowing the disease spectrum and identifying causative genetic abnormalities.


Subject(s)
Spasms, Infantile/genetics , Spasms, Infantile/physiopathology , Brain/physiopathology , Child , Child, Preschool , Electroencephalography , Exome , Female , Genetic Predisposition to Disease , Humans , Infant , Male , Movement , Movement Disorders/genetics , Mutation , NAV1.2 Voltage-Gated Sodium Channel/genetics , Nerve Tissue Proteins/genetics , Prevalence , Protein Serine-Threonine Kinases/genetics , Receptors, N-Methyl-D-Aspartate/genetics , Sequence Analysis, DNA
6.
Brain Dev ; 37(3): 356-8, 2015 Mar.
Article in English | MEDLINE | ID: mdl-24856766

ABSTRACT

Gómez-López-Hernández syndrome (GLHS) is a rare neurocutaneous syndrome characterized by the triad of rhombencephalosynapsis, trigeminal anesthesia, and bilateral parieto-occipital alopecia. We herein describe the first Japanese patient with GLHS characterized by the standard triad with typical craniofacial anomaly including hypertelorism, brachyturricephaly and midface retrusion, and a short stature. This female patient had also exhibited fever-induced convulsive seizures and psychomotor developmental delay since infancy. Brain magnetic resonance imaging showed severe rhombencephalosynapsis, supratentorial abnormalities (aplasia of the septum pellucidum, severe ventricular enlargement, and hypoplasia of the corpus callosum), and hippocampus atrophy. Bilateral ectopic cerebellums were also observed. This report describes the long-term clinical outcome of GLHS and a new neuroradiological finding regarding rhombencephalosynapsis.


Subject(s)
Abnormalities, Multiple/diagnosis , Alopecia/diagnosis , Cerebellum/abnormalities , Craniofacial Abnormalities/diagnosis , Growth Disorders/diagnosis , Neurocutaneous Syndromes/diagnosis , Abnormalities, Multiple/pathology , Abnormalities, Multiple/physiopathology , Alopecia/pathology , Alopecia/physiopathology , Cerebellum/pathology , Cerebellum/physiopathology , Child, Preschool , Craniofacial Abnormalities/pathology , Craniofacial Abnormalities/physiopathology , Female , Growth Disorders/pathology , Growth Disorders/physiopathology , Humans , Japan , Magnetic Resonance Imaging , Neurocutaneous Syndromes/pathology , Neurocutaneous Syndromes/physiopathology , Rhombencephalon/pathology , Rhombencephalon/physiopathology
7.
Brain Dev ; 37(7): 725-8, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25480382

ABSTRACT

We report a case of infantile refractory epilepsy associated with Turner syndrome (TS), showing very frequent, focal clonic seizures of the left upper extremity. Characteristically, in addition to spontaneous fits, her seizure was inducible by rubbing her left hand and forearm for a few seconds. Accordingly, she was diagnosed with a rare form of reflex epilepsy, "rub epilepsy". Neuroradiological investigation indicated the existence of cortical abnormalities, such as focal cortical dysplasia of the right parietal lobe. Patients with TS are reported to have neuroanatomical abnormalities, especially of the parietal lobe. Thus, our case may imply a causal relationship between potential cortical hyperexcitability of the parietal lobe and epilepsy in TS. This is the first reported infantile case of rub epilepsy, and more generally, reflex epilepsy associated with TS.


Subject(s)
Brain/pathology , Brain/physiopathology , Epilepsy, Reflex/pathology , Epilepsy, Reflex/physiopathology , Turner Syndrome/pathology , Turner Syndrome/physiopathology , Electroencephalography , Epilepsy, Reflex/complications , Female , Humans , Infant , Magnetic Resonance Imaging , Turner Syndrome/complications
8.
Epileptic Disord ; 16(2): 208-12, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24776920

ABSTRACT

We report a female patient who presented with intractable epileptic seizures, profound developmental delay since early infancy, and hyperkinetic movements with hand stereotypies. The patient initially developed focal seizures with multiple foci at 3 months of age. Thereafter, the seizures evolved to frequent episodes of hyperthermia-induced status epilepticus. A novel de novo SCN1A mutation was identified by whole-exome sequence analysis. This case demonstrates that SCN1A mutations may cause movement disorders as an atypical phenotype and the case history of this patient may expand our understanding of the clinical spectrum of SCN1A-associated epileptic encephalopathy. [Published with video sequences].


Subject(s)
Epilepsy/complications , Epilepsy/genetics , Hyperkinesis/complications , Hyperkinesis/genetics , NAV1.1 Voltage-Gated Sodium Channel/genetics , Stereotyped Behavior/physiology , Atrophy , Brain/pathology , Developmental Disabilities/complications , Dyskinesias/physiopathology , Epilepsy/pathology , Female , Humans , Hyperkinesis/pathology , Infant , Infant, Newborn , Magnetic Resonance Imaging , Mutation/genetics , Mutation/physiology , Status Epilepticus/complications
9.
Epilepsy Res ; 107(3): 238-43, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24269013

ABSTRACT

OBJECTIVE: To elucidate the genetic predisposition of Rasmussen syndrome (RS). METHODS: In 29 Japanese patients, we examined the genome sequences of cytotoxic T-lymphocyte-associated protein 4 (CTLA4), programmed cell-death 1 (PDCD1), and T-bet (TBX21) genes by direct sequencing, and evaluated the significance of SNPs (single nucleotide polymorphism) by comparison with Hap Map data. RESULTS: In all patients, no disease-causative mutations were found in CTLA4, PDCD1, and T-bet. However, rs231775 SNP in exon 1 of CTLA4 showed significant positive genotypic (p=0.0363) and allelic associations (p=0.0137) with onset of RS compared with Japanese controls, as did rs231779 SNP in intron 1 of CTLA4 (p=0.0467 and 0.0188, respectively). Also, rs2227982 SNP in exon 5 of PDCD1 showed significant positive genotypic and allelic associations with RS (p=0.0145 and 0.0114, respectively). Poor cognitive outcome (IQ below 50) was found in 0% of wild type (C/C), 9% of heterologous (C/T) and 25% of homologous (T/T) genotype of rs2227982. Quadriplegia was found only in homologous (T/T) genotype, and hemiplegia was in heterologous (C/T) and homologous (T/T) genotype of rs2227982. No association between SNPs of T-bet and RS onset was found. Regarding SNPs in promoter regions (rs4794067 and rs17250932) of T-bet, however, IQ below 50 was found in 19% of wild type (T/T) and 0% of heterologous (T/C) genotype of rs4794067, and in 19% of wild type (T/T) and 0% of heterologous (T/C) genotype of rs17250932. Quadriplegic patients were found only in wild-type patients (rs4794067 and rs17250932). CONCLUSIONS: We identified three SNPs (rs231775, rs231779, rs2227982) as some of the SNPs associated with onset of Japanese RS. We need further studies in other populations to confirm these genetic predispositions in RS.


Subject(s)
Asian People/genetics , CTLA-4 Antigen/genetics , Encephalitis/genetics , Genetic Variation , Programmed Cell Death 1 Receptor/genetics , T-Box Domain Proteins/genetics , Adolescent , CTLA-4 Antigen/immunology , Child , Child, Preschool , Encephalitis/immunology , Female , Genetic Predisposition to Disease , Genetic Variation/immunology , Humans , Male , Polymorphism, Single Nucleotide/genetics , Polymorphism, Single Nucleotide/immunology , Programmed Cell Death 1 Receptor/immunology , Retrospective Studies , T-Box Domain Proteins/immunology
10.
Pediatr Neurol ; 49(5): 364-7, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23916859

ABSTRACT

BACKGROUND: Mosaic variegated aneuploidy syndrome (Online Mendelian Inheritance in Man 257300), or premature chromatid separation syndrome, is a rare cancer-prone disorder associated with an autosomal recessive trait related to BUB1B gene mutations. The risk of malignancy is high, with rhabdomyosarcoma, Wilms tumor, and leukemia reported in several cases. Clinical features also include prenatal-onset growth retardation, microcephaly, mild dysmorphism, feeding difficulty, hypotonia, seizures, and developmental delay. PATIENT: A boy patient exhibited severe developmental delay, microcephaly, hypotonia, intractable seizures including infantile spasms with hypsarrhythmia at 6 months old, and Dandy-Walker malformation on magnetic resonance imaging. Seizures were refractory to conventional antiepileptics and treatment with adrenocorticotropic hormone. Wilms tumor and an unidentified intraorbital tumor also developed at 22 months old. RESULTS: Chromosomal analysis showed multiple aneuploid cells, and premature chromatid separation was found in all chromosomes in 59.5% of 119 cells, indicating mosaic variegated aneuploidy syndrome. CONCLUSIONS: The present case report demonstrates that mosaic variegated aneuploidy syndrome can be associated with developmental brain anomalies that lead to early-onset epileptic encephalopathy. Awareness of this disorder is important not only for proper diagnosis but also for genetic counseling of the family.


Subject(s)
Chromosome Disorders/complications , Developmental Disabilities/complications , Spasms, Infantile/complications , Aneuploidy , Humans , Infant , Karyotyping , Magnetic Resonance Imaging , Male , Microcephaly/etiology , Mosaicism
11.
Brain Dev ; 34(7): 601-4, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22001500

ABSTRACT

Rett syndrome (RTT) is a neurodevelopmental disorder that is one of the most common causes of mental retardation in females. RTT diagnosis is based on distinct clinical criteria. We describe here a female patient with severe phenotype of congenital variant RTT. The patient originally presented with severe developmental delay prior to the age of 6 months and later exhibited characteristic features of RTT that included air swallowing, bruxism, and hand stereotypies. Results of an array-based comparative genomic hybridization analysis indicated there was a very small microdeletion in Xq28. Multiplex ligation-dependent probe amplification analysis further confirmed there were heterozygous deletions of intron 2, exon 3, intron 3, and part of exon 4 in MECP2. Findings in the present patient confirm the view that large MECP2 deletions are an important cause of severe congenital variant RTT. To ensure an accurate diagnosis of congenital variant RTT, a multiplex ligation-dependent probe amplification analysis of MECP2 should be performed in patients suspected of having this disorder.


Subject(s)
Intellectual Disability/genetics , Methyl-CpG-Binding Protein 2/genetics , Rett Syndrome/genetics , Sequence Deletion/genetics , Comparative Genomic Hybridization , Female , Humans , Infant, Newborn , Mutation/genetics , Rett Syndrome/diagnosis
12.
Am J Med Genet A ; 155A(10): 2584-8, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21910242

ABSTRACT

FOXG1 on chromosome 14 has recently been suggested as a dosage-sensitive gene. Duplication of this gene could cause severe epilepsy and developmental delay, including infantile spasms. Here, we report on a female patient diagnosed with maternal uniparental disomy of chromosome 14 and West syndrome who carried a small supernumerary marker chromosome. A chromosomal analysis revealed mosaicism of 47,XX, + mar[8]/46,XX[18]. Spectral karyotyping multicolor fluorescence in situ hybridization analysis confirmed that the marker chromosome was derived from chromosome 14. A DNA methylation test at MEG3 in 14q32.2 and microsatellite analysis using polymorphic markers on chromosome 14 confirmed that the patient had maternal uniparental disomy 14 as well as a mosaic small marker chromosome of paternal origin containing the proximal long arm of chromosome 14. Microarray-based comparative genomic hybridization analysis conclusively defined the region of the gain of genomic copy numbers at 14q11.2-q12, encompassing FOXG1. The results of the analyses of our patient provide further evidence that not only duplication but also a small increase in the dosage of FOXG1 could cause infantile spasms.


Subject(s)
Chromosomes, Human, Pair 14/genetics , Forkhead Transcription Factors/genetics , Gene Duplication/genetics , Mosaicism , Nerve Tissue Proteins/genetics , Spasms, Infantile/genetics , Spasms, Infantile/pathology , Uniparental Disomy/genetics , Comparative Genomic Hybridization , Cytogenetic Analysis , Female , Humans , In Situ Hybridization, Fluorescence , Infant , Karyotyping , Microsatellite Repeats/genetics
13.
Epileptic Disord ; 13(3): 229-39, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21926050

ABSTRACT

INTRODUCTION: MRI data is essential for early diagnosis and evaluation of surgical indication in patients with Rasmussen syndrome (RS). In the present study, we examined the status and evolutionary changes in MRI lesions to identify the MRI characteristics of RS. METHODS: MRI of 15 RS patients was examined regarding frequency and distribution of atrophic lesions on T1-weighted images and high intensity lesions on FLAIR or T2-weighted images. RESULTS: In 13 patients, atrophic lesions were observed predominantly in the frontal lobes with various extent of involvement. High intensity lesions were also observed in 13 patients. High intensity lesions were significantly more prevalent in the cortex of patients with later onset and were present in the insula in 37.5% of epilepsia partialis continua (EPC) type patients and in 57.1% of non-EPC type. Early MRI showed various combinations of atrophic lesions or high intensity lesions in seven of nine patients who underwent MRI examinations within one year of their first seizure. Serial MRI revealed high intensity lesions with characteristic features of regression (20.0% of patients), fluctuation (regression followed by reappearance; 33.3%) and expansion (46.7%). Appearance and reappearance of high intensity lesions in the cortex and/or subcortical white matter were associated with aggravation of seizures. Bilateral high intensity lesions were observed in three patients with unilateral epileptogenic foci, who were successfully treated by surgical intervention. CONCLUSION: Dynamic evolutionary changes in lesions (regression, fluctuation and expansion of high intensity lesions), as observed on MRI, may be a diagnostic feature of Rasmussen syndrome.


Subject(s)
Brain/pathology , Encephalitis/pathology , Adolescent , Adult , Age of Onset , Atrophy , Child , Child, Preschool , Disease Progression , Female , Functional Laterality/physiology , Humans , Longitudinal Studies , Magnetic Resonance Imaging , Male , Seizures/epidemiology , Seizures/etiology , Young Adult
14.
J Child Neurol ; 26(7): 885-90, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21325126

ABSTRACT

The authors describe herein the magnetoencephalographic findings and long-term outcome of a girl with acquired opercular epilepsy with oromotor dysfunction. She presented with brief episodes of unconsciousness, tremulous movements of the upper limbs, and negative myoclonus, in addition to convulsive seizures. She also had prolonged episodes of dysarthria and oral motor dysfunction, a gradual decrease in speech output, impairment of finger movements, and deterioration in cognitive performance over several years. Her electroencephalography (EEG) recordings showed notable continuous sharp or sharp-slow discharges during sleep. Brain magnetic resonance images revealed no structural anomalies. Magnetoencephalographic analysis showed broadly distributed epileptic foci around the sylvian fissure, including a secondary source, explaining the specific prolonged neurological dysfunction. Antiepileptic drugs could control her seizures; however, they did not improve the other neurological symptoms or epileptiform discharge on EEG. Administration of low-dose prednisolone over a long period was effective for improving the neurological impairments of this patient.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Dysarthria/physiopathology , Epilepsy/physiopathology , Landau-Kleffner Syndrome/physiopathology , Motor Cortex/physiopathology , Movement Disorders/physiopathology , Child , Dysarthria/drug therapy , Epilepsy/drug therapy , Female , Humans , Landau-Kleffner Syndrome/drug therapy , Magnetoencephalography/methods , Movement Disorders/drug therapy , Treatment Outcome
15.
Am J Med Genet A ; 155A(1): 130-3, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21204220

ABSTRACT

We report on a female patient with Dandy-Walker malformation possibly caused by heterozygous loss of ZIC1 and ZIC4. The patient presented with mental retardation, epilepsy, and multiple congenital malformations including spina bifida, mild dysmorphic facial features including, thick eyebrows, broad nose, full lips, macroglossia, and hypoplasia of the cerebellar vermis with enlargement of the fourth ventricle on brain magnetic resonance imaging, which is consistent with Dandy-Walker malformation. A chromosome analysis showed interstitial deletion of chromosome 3q23-q25.1. Fluorescence in situ hybridization (FISH) and microarray-based genomic analysis revealed the heterozygous deletion of ZIC1 and ZIC4 loci on 3q24. Her facial features were not consistent with those observed in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) involving FOXL2 abnormality. Other deleted genes at 3q23-25.1 might contribute to the dysmorphic facial appearance. A milder phenotype as the Dandy-Walker malformation in our patient supports the idea that modifying loci/genes can influence the development of cerebellar malformation.


Subject(s)
Chromosome Deletion , Chromosomes, Human, Pair 3/genetics , Dandy-Walker Syndrome/genetics , Nerve Tissue Proteins/genetics , Phenotype , Transcription Factors/genetics , Dandy-Walker Syndrome/pathology , Female , Humans , In Situ Hybridization, Fluorescence , Microarray Analysis
16.
Epileptic Disord ; 13(4): 417-21, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22258047

ABSTRACT

Early-onset absence epilepsy refers to patients with absence seizures beginning before age four and comprises a heterogeneous group of epilepsies. Onset of absence seizures in the first year of life is very rare. We report a girl with intractable absence seizures with onset at age eight months. Her seizures were characterised by loss of responsiveness, with eyes drifting upwards and some myoclonic jerks of the upper and lower limbs. These symptoms were accompanied by bilaterally symmetric high-amplitude 2-2.5 Hz generalised spike-and-wave discharges on the electroencephalogram. Her seizures were refractory to conventional antiepileptic drugs; treatment with adrenocorticotropic hormone was transiently effective. Comprehensive metabolic screening, cytogenetic, and genetic analysis did not determine an underlying cause of her condition. Patients with intractable, very early-onset absence epilepsy with a myoclonic component have an unfavourable outcome and may be classified under a new epileptic syndrome, such as "early infantile absence epilepsy".


Subject(s)
Epilepsy, Absence/physiopathology , Adrenocorticotropic Hormone/therapeutic use , Adult , Age of Onset , Anticonvulsants/therapeutic use , Developmental Disabilities/complications , Drug Resistance , Electroencephalography/drug effects , Epilepsy, Absence/complications , Epilepsy, Absence/drug therapy , Female , Humans , Infant , Pregnancy , Recurrence , Seizures/physiopathology , Seizures/psychology , Treatment Outcome
17.
Brain Dev ; 32(6): 445-53, 2010 Jun.
Article in English | MEDLINE | ID: mdl-19942389

ABSTRACT

PURPOSE: Rasmussen's encephalitis (RE) is a progressive and catastrophic epileptic disorder caused by chronic localized encephalitis. We performed a nationwide survey of RE to assess the clinical picture, treatment effect, and prognosis of Japanese RE patients. SUBJECTS & METHODS: The subjects were 27 patients (male:12; female:15) from 13 medical facilities. All of them satisfied the clinical and neuroimaging criteria for RE, including 14 pathologically proven cases. RESULTS: They were divided into the childhood-onset rapidly progressive type (CORP, n=19), and late-onset slowly progressive type (LOSP, n=8). The mean age at epilepsy onset was 4 years and 4 months in CORP, and 16 years in LOSP. The mean period between the onset age of epilepsy and development of frequent seizures was 1 year and 4 months in the former, and 3 years and 4 months in the latter. The immunomodulatory treatment including high-dose steroid (n=14) and high-dose intravenous immunoglobulin therapies (IVIgG, n=12) achieved more than a 50% reduction in the seizure frequency in 5 (36%) and 4 (33%) patients, respectively. Eight and seven patients underwent focal cortical resection and functional hemispherectomy, leading to significant improvement in 5 of the 8 patients and excellent seizure control in all 7 patients, respectively. CONCLUSION: Although the high-dose steroid and IVIG therapies may have alleviated the exacerbation of seizures in those with RE, they could not halt the disease progression. Functional hemispherectomy is still the only curative therapy for RE, despite the fact that the early introduction of this procedure remains controversial.


Subject(s)
Encephalitis/epidemiology , Adolescent , Adult , Age of Onset , Brain/drug effects , Brain/pathology , Brain/surgery , Child , Child, Preschool , Cohort Studies , Disease Progression , Encephalitis/diagnosis , Encephalitis/therapy , Epilepsy/diagnosis , Epilepsy/epidemiology , Epilepsy/therapy , Female , Humans , Incidence , Infant , Japan/epidemiology , Male , Prognosis , Surveys and Questionnaires , Young Adult
18.
Pediatr Neurol ; 38(2): 104-10, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18206791

ABSTRACT

Focal spike activities in Panayiotopoulos syndrome involve all brain regions in electroencephalography, and commonly reveal multiple foci, often through occipital predominance. To investigate correlations between developmental brain maturation and spike origin in Panayiotopoulos syndrome, we evaluated age-related or duration-related magnetoencephalographic spike localization in 25 patients with Panayiotopoulos syndrome. Regarding age at examination, patients with frontal spikes were significantly older than patients with spikes on rolandic, parieto-occipital, or calcarine sulci. Occipital spikes were classified into two subgroups, located at the calcarine sulcus and parieto-occipital sulcus. Both calcarine and parieto-occipital localizations were seen in patients around the same age. Follow-up magnetoencephalography was performed on three patients, and demonstrated shifting localization or disappearance of magnetoencephalographic spikes. These results suggest that the location of spike discharges is not directly related to seizure symptoms, but instead indicates maturation-related cortical hyperexcitability in patients with Panayiotopoulos syndrome.


Subject(s)
Autonomic Nervous System Diseases/physiopathology , Brain/growth & development , Brain/physiopathology , Magnetoencephalography , Seizures/physiopathology , Adolescent , Age of Onset , Aging/physiology , Child , Child, Preschool , Data Interpretation, Statistical , Electroencephalography , Female , Humans , Magnetic Resonance Imaging , Male , Syndrome
19.
Brain Dev ; 30(5): 349-55, 2008 May.
Article in English | MEDLINE | ID: mdl-18065176

ABSTRACT

Numerous numbers of pre-, peri- and postnatal damages cause West syndrome in early infancy, however, etiology in many cases are not still elucidated despite intensive biochemical and neuroradiologic investigations. We described four patients having early onset epileptic encephalopathy with severe hypomyelination and reduction in cerebral white matter. The clinical symptoms of these patients are impaired visual attention, acquired microcephaly, spastic tetraplegia, profound psychomotor delay and infantile spasms since early infancy. All patients had striking hypomyelination of cerebrum, reduced volume of white matter and cortical atrophy on MRI. Serial MRI investigations in three patients showed absence of myelination of the white matter. On EEG, one patient revealed suppression-burst and other three had hypsarrhythmia. Despite having intractable seizures, no patient showed deterioration of neurological development. The group of these findings is mimicking to clinical manifestations of 3-phosphoglycerate dehydrogenase deficiency, and has some overlap with progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO) like syndrome, however it is not compatible with these two conditions. The findings observed in our patients can be regarded as a new clinical condition associated with early onset West syndrome.


Subject(s)
Cerebral Cortex/pathology , Demyelinating Diseases/pathology , Spasms, Infantile/pathology , Demyelinating Diseases/complications , Electroencephalography , Female , Humans , Infant , Magnetic Resonance Imaging , Male , Spasms, Infantile/complications
20.
Pediatr Neurol ; 37(2): 148-51, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17675034

ABSTRACT

We report the clinical manifestations of a 26-month-old Japanese girl with megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome. She was born to healthy, nonconsanguineous parents at 37 weeks by caesarian section after prenatal ultrasonography suggested hydrocephalus. Macrocephaly and polydactyly of both lower extremities were noted at birth. At 3 months of age, epileptic seizures developed. The patient displayed impaired vision and profound global developmental delay. Magnetic resonance imaging of the brain revealed dilatation of the lateral and third ventricles with cavum septi pellucidi et vergae and generalized polymicrogyria, most prominent in both perisylvian regions and the right frontal region. Despite ventriculomegaly, radionuclide cisternography indicated normal cerebrospinal circulation, suggesting that pathogenesis of the megalencephaly was unrelated to obstructive hydrocephalus. Decreased white matter volume and abnormal signal intensity in the occipital lobes were also noted. Visual disturbance due to white matter abnormality appears to represent a significant characteristic of this syndrome. The genetic background of the syndrome remains unclear.


Subject(s)
Abnormalities, Multiple/pathology , Brain/abnormalities , Hydrocephalus/pathology , Polydactyly/diagnostic imaging , Child, Preschool , Developmental Disabilities/pathology , Epilepsy/pathology , Female , Humans , Magnetic Resonance Imaging , Radiography , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL